Treatment and Relief of Neurological Pain
Depression
Depression significantly affects quality of life, causing mental and physical suffering. Compare the effectiveness of conventional treatments with our advanced neurological approaches.
Important
It is important to note that the improvements only relate to the direct symptoms of depression, and the patient's general clinical condition is disregarded. Side effects are disregarded from the improvement rates, as long as they don't prevent improvement in the symptoms of depression. Therapies such as EMT/TMS fulfil the need to treat the illness alongside the patient, rather than treating the illness to the detriment of their general well-being. This page contains relevant background information on Depression and the treatments offered. It is crucial to discuss your specific case with a healthcare professional.
How does our treatment work?
Transcranial Magnetic Stimulation (TMS) uses focussed magnetic fields to stimulate specific areas of the brain associated with depression. This non-invasive treatment demonstrates superior efficacy compared to antidepressant drugs, especially in cases resistant to conventional treatments. TMS does not have the common side effects of medication, such as weight gain, sexual dysfunction or drowsiness.
✓ Fast results
Many patients report the first improvements within the first few weeks of treatment, while medication can take 5-7 weeks.
✓ Duration of Effect
The positive effects of TMS can last from 6 months to 1 year after treatment, with periodic maintenance sessions. In many cases, using psychotherapeutic approaches, it is possible to achieve complete remission of symptoms
Neuropathic Pain
Neuropathic pain results from lesions or dysfunctions in the nervous system and is often resistant to conventional painkillers. Compare the effectiveness of treatments.
Important
It's worth noting that these statistics only consider improvements of more than 50% in the frequency and intensity of pain. Improvements of 20, 30, 40% are extremely relevant in the treatment of conditions such as Neuropathic Pain. This section contains relevant background information on Neuropathic Pain and the treatments presented. It is crucial to discuss your specific case with a healthcare professional.
How does our treatment work?
Transcranial Direct Current Stimulation (tDCS) applies a low-intensity electric current to modulate neuronal activity in specific areas of the brain. This non-invasive treatment has been shown to significantly reduce neuropathic pain by adjusting the neural circuits involved in pain perception and processing, offering relief where conventional medications fail.
✓ No Significant Side Effects
Unlike many neuropathic pain medications, tDCS does not cause sedation, addiction or liver toxicity.
✓ Personalised treatment
Stimulation can be adjusted specifically to your type of neuropathic pain and location, maximising results.
Migraine
Migraines can be debilitating, significantly affecting quality of life. Compare the effectiveness of conventional treatments with our advanced neurological approaches.
Important
It's important to note that the data presented refers only to the reduction in the frequency of episodes (MMD). EMT/TMS also affects the intensity of the pain. This section contains relevant background information on Migraine and the treatments presented. It is crucial to discuss your specific case with a healthcare professional.
How does our treatment work?
TMS for migraines focuses on brain areas involved in pain and migraine processes. This non-drug treatment has been shown to be effective in both the prevention and treatment of acute crises, reducing the frequency, intensity and duration of migraines in patients who do not respond to conventional treatments.
✓ Frequency reduction
Patients report an average reduction of 45% in the frequency of migraines after a full course of treatment.
✓ Long-term relief
Many patients maintain the benefits for 3-6 months after the end of the treatment cycle. In some cases, complete temporary remission of symptoms or even definitive remission is possible.
Fibromyalgia
Fibromyalgia is characterised by widespread pain and tenderness at multiple points in the body and is often resistant to conventional treatments.
Important
This section contains relevant background information on Fibromyalgia and the treatments presented. It is crucial to discuss your specific case with a healthcare professional.
How does our treatment work?
The combined approach of TMS and tDCS aims to modulate pain pathways and improve damaged sensory processing in fibromyalgia. This specific protocol shows superior results to conventional drugs, reducing generalised pain, improving sleep quality and reducing the fatigue associated with fibromyalgia.
✓ Comprehensive Relief
The treatment not only reduces pain, but also improves other symptoms such as fatigue, sleep disturbances and mental clarity.
✓ Reducing the Use of Medicines
More than 70% of patients manage to reduce their pain medication very significantly after treatment.
Insomnia
Chronic insomnia profoundly affects physical and mental health, contributing to the development of various conditions and reducing quality of life.
Important
It's important to note that the treatment of Insomnia brings with it a determining factor - the risk of addiction. Neurotherapy solves this problem. The intensive and prolonged use of sleep drugs has severe consequences that should be avoided. This section contains relevant background information on Insomnia and the treatments presented. It is crucial to discuss your specific case with a healthcare professional.
How does our treatment work?
TMS acts on the brain regions responsible for controlling sleep and circadian rhythm. This non-drug treatment normalises altered brain activity patterns in patients with insomnia, improving both sleep quality and total time slept, without the side effects and risks of dependence associated with hypnotic drugs.
✓ Improved Sleep Quality
Patients report not only more sleep, but also more restful and restorative sleep.
✓ No Risk of Dependence
Unlike many insomnia medications, TMS does not cause dependence or tolerance, even with prolonged use.
Sources
- K. Cress, MD, 2015
- Dalhuisen I, van Oostrom I, Spijker J, Wijnen B, van Exel E, van Mierlo H, de Waardt D, Arns M, Tendolkar I, van Eijndhoven P. rTMS as a Next Step in Antidepressant Nonresponders: A Randomised Comparison With Current Antidepressant Treatment Approaches. Am J Psychiatry. 2024 Sep 1;181(9):806-814. doi: 10.1176/appi.ajp.20230556. Epub 2024 Aug 7. PMID: 39108161.
- Dunner DL, Aaronson ST, Sackeim HA, Janicak PG, Carpenter LL, Boyadjis T, Brock DG, Bonneh-Barkay D, Cook IA, Lanocha K, Solvason HB, Demitrack MA. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. J Clin Psychiatry. 2014 Dec;75(12):1394-401. doi: 10.4088/JCP.13m08977. PMID: 25271871.https://pubmed.ncbi.nlm.nih.gov/25271871/
- Nguyen KH, Gordon LG. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression. Value Health. 2015 Jul;18(5):597-604. doi: 10.1016/j.jval.2015.04.004. PMID: 26297087.
- Demitrack MA, Thase ME. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data. Psychopharmacol Bull. 2009;42(2):5-38. PMID: 19629020.
- Avery DH, Holtzheimer PE 3rd, Fawaz W, Russo J, Neumaier J, Dunner DL, Haynor DR, Claypoole KH, Wajdik C, Roy-Byrne P. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006 Jan 15;59(2):187-94. doi: 10.1016/j.biopsych.2005.07.003. Epub 2005 Sep 1. PMID: 16139808.
- CHUC - ULS Coimbra Neuromodulation Unit
Clinical practice: ⅔ of patients show significant improvement; no significant side effects; significant total remission (exact data unknown)
- Marilyn J. Vachè,Magnetic Stimulation for the Treatment of Major Depressive Disorder in a Severely Treatment Resistant Population- A Retrospective Private Practice Evaluation,Brain Stimulation,Volume 8, Issue 5,2015,Page e6,ISSN 1935-861X,https://doi.org/10.1016/j.brs.2015.07.021.
- Mountain Vista, retrospective clinical analysis
- Portuguese Journal of Psychiatry and Mental Health
- WHO
- NIH, USA
- Effect of Insomnia on Repetitive Transcranial Magnetic Stimulation Treatment Outcomes for Depression, Jamie Kweon, Andrew Fukuda, Polly Gobin, Lamaan Haq, Joshua C. Brown, Linda L. CarpentermedRxiv 2023.12.06.23299444; doi: https://doi.org/10.1101/2023.12.06.23299444
